Affimed NV (AFMD) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?
Yahoo FinanceNov 19 18:33 ET
Express News | Cantor Fitzgerald Reiterates Overweight on Affimed
BenzingaNov 19 09:17 ET
Stifel Maintains Affimed NV(AFMD.US) With Hold Rating, Cuts Target Price to $4
Moomoo NewsNov 15 08:31 ET · Ratings
Affimed Is Maintained at Hold by Stifel
Dow JonesNov 15 08:20 ET · Ratings
Express News | Affimed NV : Stifel Cuts Target Price to $4 From $5
ReutersNov 15 07:53 ET
Affimed Analyst Ratings
BenzingaNov 15 07:26 ET · Ratings

Comments

Jaguar8

Nov 5 08:01

NEWS

$Affimed NV (AFMD.US)$
Affimed Announces Acceptance of Three Abstracts at the 2024 ASH Annual Meeting Including an Oral Presentation Underscoring Advancing Clinical Pipeline in Leukemia and Lymphoma

Trytosaveabit

Sep 5 05:33

Make a note of possible upcoming catalysts.

$Affimed NV (AFMD.US)$ Upcoming Milestones:
-- LuminICE-203: Efficacy update of cohorts 1-4 expected to be presented at
a future scientific conference in Q4 2024.
-- AFM24-102: ORR and safety data from the EGFRwt cohort in Q4 2024.
-- AFM28-101: Data from the study is expected to be presented at a
scientific conference in Q4 2024.
-- AMF24-102: Mature PFS data from EGFRmut and EGFRwt cohorts expected to be
presented at a future conference in H1...

Goodjobguys

Aug 1 09:43

7 Cheap But Risky Biotech Stocks? Funds moving from big corporations to Small Caps?

$Immuneering (IMRX.US)$ $SPDR S&P Biotech ETF (XBI.US)$ $iShares Biotechnology ETF (IBB.US)$ $S&P 500 Index (.SPX.US)$ $BioAtla (BCAB.US)$ $Gilead Sciences (GILD.US)$ $Affimed NV (AFMD.US)$ $Instil Bio (TIL.US)$ $Nkarta (NKTX.US)$
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF XBI 0.05% drop nearly 50%.
The other most-watched exchange-traded fund that tracks the biotech secto...

10

1

Trytosaveabit

Jun 12 07:05

For you notes!

$Affimed NV (AFMD.US)$ Upcoming Milestones: • Data readout from the 12 patients in cohorts 1 and 2 of the LuminICE-203 (AFM13 combination with AlloNK® cells) study in Q3 2024.
• ORR and PFS data from the 25 patients in the EGFRmut cohort of the AFM24-102 study in Q3 2024.
• ORR and PFS data from the 40 patients in the EGFRwt cohort of the AFM24-102 study in Q4 2024.

NinjaTradez

Jun 3 21:42

Tradershub.ninja

$Avalon GloboCare (ALBT.US)$ $Affimed NV (AFMD.US)$ $Structure Therapeutics (GPCR.US)$ $Finch Therapeutics (FNCH.US)$
On fire

1

AFMD Affimed NV

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target